http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1605960-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7f871411f032ed0fb0e077a4ae2816f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2235 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N- |
| filingDate | 2004-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14ab18cb4563e96cd80e1512cdf9c8a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_873f57e6e54a3288d75ec9ef3baff186 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bd7982c8fa8dd0f9ca1242678d4eb58 |
| publicationDate | 2005-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1605960-A2 |
| titleOfInvention | Use of secretin and secretin analogs to treat affective disorders |
| abstract | The invention is based, in part, on the discovery that secretin and secretin analogs can be used to treat affective disorders that include symptoms of anxiety. Secretin and secretin analogs can be administered to patients to treat affective disorders, such as mood, psychotic, mental, substance-abuse withdrawal, eating, and sexual disorders, as well as other disorders with attendant sensory processing dysfunction, including symptoms of anxiety and/or fear. In addition, secretin and secretin analogs can be administered to improve cognition, including learning and memory, as well as to lessen the effects of conditioned startle. Secretin has the added benefit of causing no negative side effects upon administration and being easy to administer. |
| priorityDate | 2003-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 257.